Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02390401 · ClinicalTrials.gov registry record · Phase 1

Vacuum Assisted Closure for Cesarean Section

A Phase 1 study, sponsored by Dartmouth-Hitchcock Medical Center.

Terminated
Registry status
Phase 1
Development phase
166
Enrollment target

NCT02390401 is a Phase 1 study that was terminated before completion, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 166 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02390401, a Phase 1 study, was terminated before completion, sponsored by Dartmouth-Hitchcock Medical Center.

TERMINATED
Registry status
Phase 1
Development phase
166 participants
Enrollment target

Study Summary

To study if incisional vacuum-assisted closure can decrease the risk of infection in cesarean section incisions in the obese compared with standard sterile dressing.

Interventions

  • DEVICE Vacuum-assisted closure
  • DEVICE Standard sterile dressing

Trial Details

FieldValue
Enrollment Target 166 participants
Start Date 2015-05
Est. Completion 2017-09
Phase Phase 1

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT02390401

The ClinicalTrials.gov registry entry for NCT02390401 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Vacuum-assisted closure is the first listed.

NCT02390401 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02390401 about?

NCT02390401 is a clinical study titled "Vacuum Assisted Closure for Cesarean Section". To study if incisional vacuum-assisted closure can decrease the risk of infection in cesarean section incisions in the obese compared with standard sterile dressing.

What is the current status of trial NCT02390401?

This trial is currently terminated. It is a Phase 1 study. The enrollment target is 166 participants. The study started on 2015-05. Estimated completion is 2017-09.

What interventions are being tested in trial NCT02390401?

The interventions under investigation include: Vacuum-assisted closure (DEVICE), Standard sterile dressing (DEVICE).

Who is sponsoring clinical trial NCT02390401?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.